How to Restart Semaglutide After 1 Month

Summary: If you have been off semaglutide longer than five weeks, the FDA-aligned restart is 0.25 mg weekly and a full re-titration; under two weeks, you usually resume your previous dose.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: if you have been off semaglutide for more than five weeks, you restart at 0.25 mg once weekly and walk back up the titration ladder. If you have been off for less than two weeks, you usually resume your previous dose without a re-titration. One month falls in the middle, and that is the gap that confuses everyone. The right call depends on exactly when your last shot was, what dose you were on, and how your gut tolerated escalation the first time around.

Below is the FDA-aligned protocol, the half-life math that explains why the five-week line exists, and what to expect when steady state rebuilds.

The fast answer by length of break

The FDA labels for Ozempic and Wegovy both spell out the missed-dose window. Within five days of the scheduled day, you can take the missed dose. Past five days, skip it and take the next dose on the regular weekly schedule ^[1][2]. Both labels recommend reinitiating the titration if you have missed two or more consecutive doses, which is the practical rule that drives the rest of this article.

Why five weeks is the line

Semaglutide has a half-life of about one week ^[1][2]. That is unusually long for an injectable peptide, and it is the engineering trick that makes once-weekly dosing work in the first place. The standard pharmacology rule is that a drug reaches steady state in roughly five half-lives, and it washes out in roughly five half-lives. For semaglutide that math comes out to about five weeks in both directions.

If you take your last shot today and never inject again, drug levels in your blood drop by half every seven days. After one week you are at 50 percent. After two weeks, 25 percent. After three weeks, 12.5 percent. After four weeks, around 6 percent. After five weeks, around 3 percent and effectively gone ^[1][2]. Your GI tract, which had adapted to the steady-state slowing of gastric emptying, no longer has anything to adapt to. The tolerance you built dose by dose during your original titration is gone.

Restarting at your previous maintenance dose after that washout would dump a therapeutic concentration of semaglutide into a naive gut all over again. The result is what people felt the first time they jumped levels too fast: relentless nausea, vomiting, sometimes dehydration severe enough to risk acute kidney injury. The titration schedule exists specifically to prevent that, and the restart protocol exists for the same reason.

At 1 month off, you are close to that washout line. Some prescribers will still let you restart at a step below your last dose if you tolerated escalation well originally and only had a short gap. Others will reset you to 0.25 mg. The conservative choice is to re-titrate. The aggressive choice is to step back one level. Both are defensible. Neither one is "skip ahead to your old maintenance dose," and that is the answer you should not accept from anyone.

The exact restart protocol after a one-month break

If your prescriber agrees that a full re-initiation is appropriate, you walk back up the same ladder the FDA label prescribes for new starts.

Ozempic (type 2 diabetes)

• Weeks 1 to 4: 0.25 mg once weekly. This is the initiation dose. It is not therapeutic for blood sugar control; it exists to rebuild gut tolerance.
• Weeks 5 to 8: 0.5 mg once weekly. Most people start to see appetite and glucose effects here.
• Weeks 9 to 12: 1 mg once weekly, if needed for glycemic targets.
• Weeks 13 onward: 2 mg once weekly, the maximum approved dose ^[1].

Wegovy (chronic weight management)

• Weeks 1 to 4: 0.25 mg once weekly.
• Weeks 5 to 8: 0.5 mg.
• Weeks 9 to 12: 1 mg.
• Weeks 13 to 16: 1.7 mg.
• Week 17 onward: 2.4 mg, the maintenance dose ^[2].

The Wegovy label specifically notes that if you do not tolerate a dose, you can stay at the previous dose for another four weeks before stepping up again. That flexibility belongs in your restart plan too. If 0.5 mg made you nauseous on the way back up, hold there for an extra month before escalating to 1 mg. Re-titrating is not a race.

What about a shorter break

What to expect when you restart

The side effects you got the first time are going to come back, at least partially. The trial data and clinical experience both agree on this. Nausea, occasional vomiting, constipation, fatigue, and the appetite suppression itself all return as drug levels climb back toward steady state. The good news is that the second titration is usually easier than the first. Your body remembers. Most people tolerate the second 0.25 mg phase with less GI drama than they had originally, even though the dose is identical.

A few specifics worth planning for:

Appetite suppression returns gradually, not instantly. During your first 0.25 mg week back, you probably will not notice much. By week two or three the food noise quiets down again. Steady-state appetite control usually returns once you reach 1 mg or higher, which puts you about 8 to 12 weeks into the re-titration.

Nausea peaks during the week after each step-up. Days 3 to 5 after you escalate are statistically the worst window. Plan around it. Small meals, low-fat foods, avoid the combination of large portion plus high fat plus alcohol that reliably triggers vomiting on GLP-1 therapy.

Weight loss does not pick up where it left off. If you regained weight during the break (and roughly two-thirds of weight lost typically returns after stopping semaglutide for a year ^[4]), the new starting weight is just that, a new starting weight. The trajectory back down resembles the first time. The STEP 1 trial averaged 14.9 percent body weight loss at 68 weeks on 2.4 mg ^[3]. A restart aiming at the same maintenance dose follows a similar timeline.

Blood sugar in diabetes patients can swing during the gap and the re-titration. If you are on semaglutide for type 2 diabetes, the month off probably let your A1c drift up. Your provider may keep you on other agents (metformin, an SGLT2 inhibitor) at adjusted doses during the re-titration so your glucose does not spike while you are still climbing back toward a therapeutic semaglutide level.

Restarting after surgery

This is one of the most common reasons for a one-month-plus gap, so it deserves its own answer.

Whether semaglutide should be held before surgery has been a moving target. The 2023 American Society of Anesthesiologists guidance recommended holding GLP-1 drugs before procedures involving anesthesia, citing the risk of retained gastric contents from slowed gastric emptying and the aspiration risk that creates. The 2024 multi-society guidance softened that position. It now allows most patients to continue GLP-1 receptor agonists perioperatively, with a 24-hour clear liquid diet before the procedure, individualized risk assessment, and selective use of gastric ultrasound for higher-risk patients ^[5]. Patients with significant GI symptoms or those early in dose escalation may still be advised to hold.

If your team did hold semaglutide for a month around surgery, the same washout math applies. After five-plus weeks off, restart at 0.25 mg and re-titrate. Restart only after your surgeon clears you for normal eating and you are not still managing post-operative nausea, slow gut motility, or wound healing complications. Bariatric surgery is its own case. After gastric sleeve or gastric bypass, the decision to restart a GLP-1 agonist hinges on weight regain trajectory and the surgeon's protocol. The drug remains safe and effective after bariatric surgery, but the timing and target dose should be coordinated with both the bariatric team and the prescribing clinician.

What is genuinely different at the one-month mark

A 1-month break is the awkward gap where neither the "just keep going" answer nor the "full reset" answer is obviously right. Three factors push toward a full re-titration:

1. Pharmacology. At 4 weeks off, drug levels are around 6 percent of steady state. Your gut has already lost most of its adaptation.
2. Tolerance trajectory. The original titration was designed around 4-week intervals because that is roughly the time the GI system needs to adjust to each dose increment. Four weeks off is one full adjustment cycle gone in reverse.
3. Risk asymmetry. Restarting at 0.25 mg and feeling fine costs you 8 to 12 weeks to get back to maintenance. Restarting at your previous maintenance dose and triggering severe vomiting costs you an ER visit and potentially weeks of recovery. The downside of the conservative path is small; the downside of the aggressive path is not.

Two factors can push toward stepping back only one level rather than full re-titration:

1. You tolerated the original escalation without significant nausea, vomiting, or diarrhea.
2. Your break was on the shorter end of one month, say 4 weeks rather than 6, and you have not had any new medical issues during the gap.

That decision belongs to your prescriber. Bring them the exact dates and the symptom history; do not show up asking to skip back to 1 mg without context.

When you should not restart

Some pauses should become full stops, not just gaps. Do not restart semaglutide if you developed any of the following during the break:

• Confirmed acute pancreatitis. The FDA labels treat this as a reason to discontinue ^[1][2].
• Suspicion of or diagnosis with medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). These are boxed-warning contraindications.
• Pregnancy, planned pregnancy within two months, or breastfeeding. Semaglutide should be stopped at least two months before a planned conception due to its long half-life ^[1][2].
• A serious hypersensitivity reaction to semaglutide. This is rare but a hard contraindication for restarting.
• New severe gastroparesis or persistent severe GI symptoms that did not resolve with dose reduction.

For everyone else, restarting is reasonable, and the question is timing and dose, not whether.

Common questions about restarting semaglutide

How to restart semaglutide after 2 weeks off?

At exactly two weeks (two missed doses), most prescribers either resume the previous dose with closer monitoring or step back one level for four weeks before re-escalating. The FDA label recommends reinitiation after two or more missed doses, so this is the gray zone where clinical judgment matters most.

How to restart semaglutide after 2 months off?

A full re-titration from 0.25 mg weekly is standard. Two months is well past five half-lives, drug levels are zero, and gut tolerance is fully reset. Expect the full 8-to-12 week climb back to your previous maintenance dose, with side effects similar to the original titration but usually milder.

Can I stop and restart semaglutide whenever I want?

Yes, semaglutide does not cause physical dependence, so there are no withdrawal symptoms. The cost of doing it repeatedly is metabolic. Each gap typically allows some weight regain and, in diabetes patients, drifting blood sugar. Frequent stops and starts also mean repeated re-titrations and repeated side-effect phases.

Do I need new lab work before restarting?

After a one-month break, usually no, unless you have had a significant medical event. After a longer gap, your provider may want to recheck kidney function, A1c if you are diabetic, and any monitoring relevant to conditions that developed during the pause.

Will I get the same appetite suppression at the same dose I had before?

Generally yes, once you climb back to that dose and steady state. The first 4 to 8 weeks of re-titration will feel weaker because you are at sub-therapeutic doses. By the time you return to 1 mg or 2.4 mg, the appetite control is comparable to what you experienced originally.

How long after restarting will I start losing weight again?

Most people see scale movement within the first 4 to 6 weeks of restarting, even at the 0.25 mg starting dose, because some appetite suppression returns quickly. Significant weight loss usually accelerates once you cross back into therapeutic dose territory at 1 mg and above.

Is restarting harder on side effects than starting the first time?

Usually it is easier, not harder. Your body has done this before. Most people report that the second titration's nausea peaks lower and resolves faster than the first. That is not a guarantee, and the same per-step plan (slow food, low fat, no alcohol on injection day plus 48 hours) still applies.

I was on Wegovy 2.4 mg. After 6 weeks off, do I really have to start at 0.25 mg again?

Yes, that is the FDA-aligned protocol. Past five half-lives the drug is gone and the gut is naive. Restarting at 2.4 mg risks severe GI toxicity. The full re-titration takes about 16 to 20 weeks to get back to 2.4 mg, and the alternative (vomiting your way through it) is worse.

Should I stop semaglutide before surgery?

The 2024 multi-society guidance allows continuation in most low-risk patients, often with a 24-hour clear liquid diet before the procedure. Patients with significant GI symptoms or those early in dose escalation may be told to hold. The decision belongs to your surgeon and anesthesiologist in coordination with your prescriber.

After a gastric sleeve or gastric bypass, can I restart semaglutide?

Yes, semaglutide remains safe and effective after bariatric surgery and is increasingly used to address weight regain or insufficient initial loss after the procedure. The restart should be coordinated with both the bariatric team and the prescribing clinician, and the titration typically follows the standard schedule starting from 0.25 mg.

What this article does not cover

This page is the restart protocol for a one-month break. Adjacent questions, like which compounding pharmacy fills semaglutide cheapest, how to manage specific side effects week by week, and how semaglutide compares to tirzepatide for weight loss, have their own dedicated pages on this site. The pharmacology and the FDA-aligned dosing rules above apply regardless of the brand name on the vial: Ozempic, Wegovy, and compounded semaglutide all contain the same active ingredient with the same one-week half-life.